Japan· JP-6419001F1048
チニダゾール
A tinidazole product containing チニダゾール, registered in Japan by 富士製薬工業, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Tinidazole is registered in 4 of 19 countries.
Countries holding a registration under ATC J01XD02 (tinidazole), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Tinidazole · ATC J01XD02
4 / 19 countries
- Belgiumprice
- Finlandprice
- Japan
- Polandprice
Price per daily dose
What a daily dose of tinidazole costs, country by country.
Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tinidazole · price per daily dose (1.5 g)
USD · FX 28 Sept 2026
- FR France$2.66
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- チニダゾール
- Manufacturer
- 富士製薬工業
- Country
- Japan (JP)
- ATC code
- J01XD02
- ATC class
- Tinidazole
- Defined daily dose
- 1.5 g, P
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
183 interactions on record for tinidazole.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tinidazole · interactions on record
183 records
- 1 severe
- 181 moderate
- 1 minor
Most severe, free to view
- AmprenavirJ05AE05severe
- LonafarnibA16AX20moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01XD02
Tinidazole, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/410048d7-8e2b-492b-93c9-3da2a396e1ea GET /v1/drugs/410048d7-8e2b-492b-93c9-3da2a396e1ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２００ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "6419001F1048",
"category": "内用薬",
"price_yen": 46.8,
"generic_name": "チニダゾール",
"product_name_jp": null,
"therapeutic_class": "6419",
"transitional_expiry": "R9.3.31まで"
}See everything about tinidazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.